Upregulated mRNA expression of major histocompatibility complex class I chain-related gene A in colon and activated natural killer cells of Chinese patients with ulcerative colitis

Journal of Digestive Diseases

Volumn 12, Issue 2, 2011, Pages 82-89

  Ge, Liu Qing ^b   Jiang, Ting ^a,c   Zhao, Jie ^a,b   Chen, Zhi Tao ^a,c   Zhou, Feng ^a   Xia, Bing ^a,b,c  

^a WUHAN UNIVERSITY   (China)

^b Clinical Research Center for Intestinal Colorectal Diseases   (China)

^c Key Laboratory of Allergy and Immune related Diseases   (China)

Author keywords

MICA; MICB; NK cell; NKG2D; Ulcerative colitis

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR NKG2D;

ADOLESCENT; ADULT; ARTICLE; BASOLATERAL MEMBRANE; CHINESE; COLON BIOPSY; COLON MUCOSA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-GAMMA; INTESTINAL MUCOSA; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; YOUNG ADULT;

EID: 79952657109     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2010.00464.x     Document Type: Article

References (34)

1. Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis 2009; 10: 1-6.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-34.
3. Borchers MT, Harris NL, Wesselkamper SC, Vitucci M, Cosman D. NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 291.
4. Hui J, Palmer LJ, Jamesw AL, Musk AW, Beilby JP. Aluy-MICB dimorphism within the class I region of the major histocompatibility complex is associated with asthma and airflow obstuction in the Busselton population. Clin Exp Allergy 2006; 36: 728-34.
5. Stastny P. Introduction: MICA/MICB in innate immunity, adaptive immunity autoimmunity, cancer, and in the immune response to transplants. Hum Immunol 2006; 67: 141-4.
6. Piancatelli D, Del Beato T, Oumhani K, EI Aouad R, Adorno D. MICA polymorphism in a population from north Morocco, Metalsa Berbers, using sequence-based typing. Hum Immunol 2006; 66: 931-6.
7. Madid Z, Spendlove I, Modd R etal. Upregulation of MICA on high-grade invasive operable breast carcinoma. Cancer Immun 2007; 7: 17.
8. Zhang T, Barber A, Sentman CL. Generation of antitumor responses by genetic modification of primary human T-cells with a chimeric NKG2d receptor. Cancer Res 2006; 66: 5927-33.
9. Xu X, Rao G, Gaffud MJ etal. Clinicopathological significance of major histocompatibility complex class I-related chain A and B expression in thyroid cancer. J Clin Endocrinol Metab 2006; 91: 2704-12.
10. Das H, Groh V, Kuijl C etal. MICA engagement by human Vgamma2Vdelta2 T-cells enhances their antigen-dependent effector function. Immunity 2001; 15: 83-93.
11. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002; 17: 19-29.
12. Maccalli C, Pende D, Castelli C, Mingari MC, Robbins PF, Parmiani G. NKG2D engagement of colorectal cancer-specific T-cells strengthens TCR mediated antigen stimulation and elicits TCR independent anti-tumor activity. Eur J Immunol 2003; 33: 2033-43.
13. Eleme K, Taner SB, Onfelt B etal. Cell surface organization of stress-inducible protein ULBP and MICA that stimulate human NK cells and T-cells via NKG2D. J Exp Med 2004; 199: 1005-10.
14. McCann FE, Eissmamm P, Onfelt B, Leung R, Davis DM. The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequence. J Immunol 2007; 178: 3418-26.
15. Holmes MA, Li P, Petersdorf EW, Sreong RK. Structural studies of allelic diversity of the MHC class I homolog MICB, a stress-inducible ligand for the activating immunoreceptor NKG2D. J Immunol 2002; 169: 1395-400.
16. Lü M, Xia B, Li J, Ye M, Zhang X, Tan Q. MICB microsatellite polymorphism is associated with ulcerative colitis in Chinese population. Clin Immunol 2006; 120: 199-204.
17. Li Y, Xia B, Lü M, Ge L, Zhang X. MICB0106 gene polymorphism is associated with ulcerative colitis in central China. Int J Colorectal Dis 2010; 25: 153-9.
18. Lü M, Xia B, Ge L etal. Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients. Immunology 2009; 128: e230-236.
19. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomize study. N Engl J Med 1987; 317: 1625-9.
20. McCann FE, Vanherberghen B, Eleme K etal. The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J Immunol 2003; 170: 2862-70.
21. Ding Y, Xia B, Lü M etal. MHC class I chain-related gene A-A5.1 allele is associated with ulcerative colitis in Chinese population. Clin Exp Immunol 2005; 42: 193-8.
22. Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2001; 2: 443-51.
23. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T-cells. Science 1998; 279: 1737-40.
24. Perera L, Shao L, Parel A etal. Expression of nonclassical class I molecules by intestinal epithelia cells. Inflamm Bowel Dis 2007; 13: 298-307.
25. Konstantina E, Sabrina B, Bjorn O, Lucy M, Fiona E. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cell and T-cells via NKG2D. J Exp Med 2004; 199: 1005-10.
26. Zafirova B, Mandarić S, Antulov R etal. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 2009; 31: 270-82.
27. Carbone E, Neri P, Mesuraca M etal. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 2005; 105: 251-8.
28. Tamaki S, Sanefuzi N, Kawakami M etal. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Hum Immunol 2008; 69: 88-93.
29. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781-90.
30. Hayakawa Y, Kelly JM, Westwood JA etal. Cutting edge: tumor rejection mediated by NKG2D receptor ligand interaction is dependent upon perforin. J Immunol 2002; 169: 5377-81.
31. Allez M, Tieng V, Nakazawa A etal. CD4+NKG2D+ T-cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 2007; 132: 2346-58.
32. Robinson P, Stuber D, Deryckere F, Tedbury P, Lagrange M, Orfanoudakis G. Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines. J Mol Recognit 2005; 18: 175-82.
33. Steinle A, Li P, Morris DL etal. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001; 53: 279-87.
34. Roda-Nacarro P, Vales-Gomez M, Chisholm SE, Revburn HT. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function. Proc Natl Acad Sci U S A 2006; 103: 11258-63.